Immunome stockIMNM
Immunome trades at $17.91, 40.4% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. −16.6% year to date, +16.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 16, 2026.
Ratings, candles, signals and the screener for IMNM — after you log in
Open the terminalFrequently asked questions about Immunome
What is the Immunome stock price?
At the close on Nov 5, 2026: $17.91 (−8.27% on the day). 52-week high: $30.06 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Immunome report earnings?
The next quarterly report is on Nov 16, 2026. Last quarter, earnings per share changed −30% year over year, revenue −100%.
Does Immunome pay dividends?
No, Immunome does not pay dividends.
Where does Immunome trade and how to buy it?
Ticker IMNM, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Immunome now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for IMNM are in the terminal after you log in.